Skip to main content
NCBI home page
British Journal of Pharmacology logoLink to British Journal of Pharmacology
. 1979 Sep;67(1):93–101.

Development of tolerance to the prolongation of Hexobarbitone sleeping time caused by cannabidiol

Henry K Borys, Glynnis B Ingall, Ralph Karler
PMCID: PMC2043607  PMID: 497524

Abstract

1 The effects of acute and subacute cannabidiol (CBD) administration on hexobarbitone sleeping time and on some constituents of the hepatic microsomal drug-metabolizing system were assessed in the mouse.

2 Acutely administered CBD prolonged sleeping time; but with subacute treatment, tolerance to the effect rapidly developed.

3 Brain hexobarbitone concentration upon awakening was unchanged by either acute or subacute CBD treatment, which suggests that neither the prolongation of sleeping time nor the tolerance is the result of a change in sensitivity of the central nervous system to the barbiturate.

4 Acute CBD treatment increased the half-time of hexobarbitone in the brain, which returned toward normal with the development of tolerance.

5 Acutely, CBD caused a 30% decrease in hepatic cytochrome P-450 level; with tolerance, the cytochrome concentration returned to normal.

6 The evidence suggests that the CBD-induced prolongation of barbiturate sleeping time and the tolerance to this effect are the result of changes in the rate of drug metabolism, which are related to changes in the amount of cytochrome P-450.

7 The effects of CBD on the hepatic microsomal drug-metabolizing enzyme system are different from those attributed to SKF 525-A and piperonyl butoxide because the cannabinoid does not decrease cytochrome P-450 quantitatively by complex formation, it does not produce a recovery overshoot in the cytochrome concentration and, finally, it does not cause an induction of the hexobarbitone-metabolizing enzymes.

Full text

PDF
93

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Buening M. K., Franklin M. R. SKF 525-A inhibition, induction, and 452-nm complex formation. Drug Metab Dispos. 1976 May-Jun;4(3):244–255. [PubMed] [Google Scholar]
  2. COOPER J. R., BRODIE B. B. The enzymatic metabolism of hexobarbital (evipal). J Pharmacol Exp Ther. 1955 Aug;114(4):409–417. [PubMed] [Google Scholar]
  3. Dalton W. S., Martz R., Rodda B. E., Lemberger L., Forney R. B. Influence of cannabidiol on secobarbital effects and plasma kinetics. Clin Pharmacol Ther. 1976 Dec;20(6):695–700. doi: 10.1002/cpt1976206695. [DOI] [PubMed] [Google Scholar]
  4. De Matteis F. Drug-induced destruction of cytochrome P-450. Drug Metab Dispos. 1973 Jan-Feb;1(1):267–274. [PubMed] [Google Scholar]
  5. Fernandes M., Kluwe S., Coper H. Cannabinoids and hexobarbital induced loss of righting reflexes. Naunyn Schmiedebergs Arch Pharmacol. 1974;283(4):431–435. doi: 10.1007/BF00501116. [DOI] [PubMed] [Google Scholar]
  6. Franklin M. R., Estabrook R. W. On the inhibitory action of mersalyl on microsomal drug oxidation: a rigid organization of the electron transport chain. Arch Biochem Biophys. 1971 Mar;143(1):318–329. doi: 10.1016/0003-9861(71)90213-x. [DOI] [PubMed] [Google Scholar]
  7. Franklin M. R. Methylenedioxyphenyl insecticide synergists as potential human health hazards. Environ Health Perspect. 1976 Apr;14:29–37. doi: 10.1289/ehp.761429. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. KATO R., CHIESARA E., VASSANELLI P. FURTHER STUDIES ON THE INHIBITION AND STIMULATION OF MICROSOMAL DRUG METABOLIZING ENZYMES OF RAT LIVER BY VARIOUS COMPOUNDS. Biochem Pharmacol. 1964 Jan;13:69–83. doi: 10.1016/0006-2952(64)90080-2. [DOI] [PubMed] [Google Scholar]
  9. Karler R., Cely W., Turkanis S. A. A study of the development of tolerance to an anticonvulsant effect of delta9-tetrahydrocannabinol and cannabidiol. Res Commun Chem Pathol Pharmacol. 1974 Sep;9(1):23–39. [PubMed] [Google Scholar]
  10. Karler R., Cely W., Turkanis S. A. The anticonvulsant activity of cannabidiol and cannabinol. Life Sci. 1973 Dec 1;13(11):1527–1531. doi: 10.1016/0024-3205(73)90141-0. [DOI] [PubMed] [Google Scholar]
  11. LOWRY O. H., ROSEBROUGH N. J., FARR A. L., RANDALL R. J. Protein measurement with the Folin phenol reagent. J Biol Chem. 1951 Nov;193(1):265–275. [PubMed] [Google Scholar]
  12. Levin W., Jacobson M., Sernatinger E., Kuntzman R. Breakdown of cytochrome P-450 heme by secobarbital and other allyl-containing barbiturates. Drug Metab Dispos. 1973 Jan-Feb;1(1):275–285. [PubMed] [Google Scholar]
  13. Levin W., Ryan D., Kuntzman R., Conney A. H. Neonatal imprinting and the turnover of microsomal cytochrome P-450 in rat liver. Mol Pharmacol. 1975 Mar;11(2):190–200. [PubMed] [Google Scholar]
  14. OMURA T., SATO R. THE CARBON MONOXIDE-BINDING PIGMENT OF LIVER MICROSOMES. I. EVIDENCE FOR ITS HEMOPROTEIN NATURE. J Biol Chem. 1964 Jul;239:2370–2378. [PubMed] [Google Scholar]
  15. Paton W. D., Pertwee R. G. Effect of cannabis and certain of its constituents on pentobarbitone sleeping time and phenazone metabolism. Br J Pharmacol. 1972 Feb;44(2):250–261. [PMC free article] [PubMed] [Google Scholar]
  16. Perez-Reyes M., Timmons M. C., Davis K. H., Wall E. M. A comparison of the pharmacological activity in man of intravenously administered delta9-tetrahydrocannabinol, cannabinol, and cannabidiol. Experientia. 1973 Nov 15;29(11):1368–1369. doi: 10.1007/BF01922823. [DOI] [PubMed] [Google Scholar]
  17. SERRONE D. M., FUJIMOTO J. M. The effect of certain inhibitors in producing shortening of hexobarbital action. Biochem Pharmacol. 1962 Jul;11:609–615. doi: 10.1016/0006-2952(62)90122-3. [DOI] [PubMed] [Google Scholar]
  18. Siemens A. J., Kalant H., Khanna J. M., Marshman J., Ho G. Effect of cannabis on pentobarbital-induced sleeping time and pentobarbital metabolism in the rat. Biochem Pharmacol. 1974 Feb 1;23(3):477–488. doi: 10.1016/0006-2952(74)90612-1. [DOI] [PubMed] [Google Scholar]
  19. Vesell E. S. Factors altering the responsiveness of mice to hexobarbital. Pharmacology. 1968;1(2):81–97. doi: 10.1159/000135949. [DOI] [PubMed] [Google Scholar]
  20. WILLIAMS C. H., Jr, KAMIN H. Microsomal triphosphopyridine nucleotide-cytochrome c reductase of liver. J Biol Chem. 1962 Feb;237:587–595. [PubMed] [Google Scholar]

Articles from British Journal of Pharmacology are provided here courtesy of The British Pharmacological Society

RESOURCES